Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/11/1998 | EP0720473B1 Budesonide pellets with a controlled release pattern and process for producing them |
11/11/1998 | EP0717742B1 Process for the preparation of indolizine derivatives |
11/11/1998 | EP0693921A4 Anti-oxidant alkylaryl polyether alcohol polymers |
11/11/1998 | EP0691970B1 Imidazoloquinoxalinone derivatives as eaa antagonists |
11/11/1998 | EP0687266B1 Heterocyclic compounds and their preparation and use |
11/11/1998 | EP0647649B1 Novel crystal of monohydrate of heterocyclic bis(phosphonic acid) derivative |
11/11/1998 | EP0641766B1 Alkoxyphenylalkylamine derivative |
11/11/1998 | EP0640074B1 Salts of a quinolone-carboxylic acid |
11/11/1998 | EP0597915B1 A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide |
11/11/1998 | EP0583271B1 Arylmorpholine, preparation and use |
11/11/1998 | EP0579826B1 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics |
11/11/1998 | EP0543015B1 Composition, method and kit for potentiating antitumor activity and for curing tumor |
11/11/1998 | CN1198775A Recombinant c-proteinase and processes, methods and uses thereof |
11/11/1998 | CN1198748A Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
11/11/1998 | CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
11/11/1998 | CN1198746A Tricyclic benzazepine vasopressin antagonists |
11/11/1998 | CN1198743A Pyrimidine derivatives as 5HT2c-receptor antagonists |
11/11/1998 | CN1198741A Imidazole derivatives having affinity for alpha 2 receptors activity |
11/11/1998 | CN1198739A (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanolmethanesulfonate trihydrate |
11/11/1998 | CN1198738A Inhibitor for narcotic analgetic dependence/resistance acquisition |
11/11/1998 | CN1198737A Endothelin antagonist |
11/11/1998 | CN1198735A Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof |
11/11/1998 | CN1198677A Isotopic urea tablets |
11/11/1998 | CN1198672A Gel for the local hormonotherapy of vaginal dryness |
11/11/1998 | CN1198671A Green porphyrins as immunomodulators |
11/11/1998 | CN1198670A Photostable aqueous solution containing benzyl alcohol derivatives |
11/11/1998 | CN1198669A Use of aminoadamantane compound as immunoregulators |
11/11/1998 | CN1198668A Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
11/11/1998 | CN1198667A Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
11/11/1998 | CN1198665A Unit galenical form for local hormonotherapy of vaginal dryness |
11/11/1998 | CN1198437A Intermediate of benzazepine derivative |
11/11/1998 | CN1198331A Medicine for curing trigeminal neuralgia |
11/11/1998 | CN1198330A Method for treating protozoal infections |
11/11/1998 | CN1198329A Medicine for eliminating tumor |
11/11/1998 | CN1040646C Enatiomeric hydroxylated xanthine compound |
11/11/1998 | CN1040645C Compound with 5-HT4 receptor rivalry activity, its preparation and pharmaceutical composition containing said compound |
11/10/1998 | US5834594 Polyethylene-protein conjugates |
11/10/1998 | US5834586 Dehydrodidemnin B |
11/10/1998 | US5834571 Gas phase polymerization process |
11/10/1998 | US5834521 Treatment of progestin mediated maladies; osteoporosis, cancer |
11/10/1998 | US5834520 Rubber-stoppered vials filled with sterile sodium 2-mercaptoethane sulfonate solution with ph value between 7.5 and 8.5; storage stability, oxidation resistance |
11/10/1998 | US5834517 Hair, skin conditioners; improved viscosity |
11/10/1998 | US5834516 Meadowfoam betaines in personal care applications |
11/10/1998 | US5834514 Halomethyl amides as IL-1β protease inhibitors |
11/10/1998 | US5834513 Oxa diacids and related compounds for treating skin conditions |
11/10/1998 | US5834512 Administering 6,9-octadecadienoic acid, 8,11-eicosadienoic acid and/or 5,8,11-eicosatrienoic acid |
11/10/1998 | US5834510 Topical application |
11/10/1998 | US5834509 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
11/10/1998 | US5834508 Ketone derivatives |
11/10/1998 | US5834507 Cytotoxic agents prepared from podophyllotoxin; antitumor and carcinogenic agents |
11/10/1998 | US5834506 Treatment of hiv, aids; antiviral activity improved by judicious placement of polar substituents |
11/10/1998 | US5834505 Antimalarial drugs |
11/10/1998 | US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition |
11/10/1998 | US5834503 Administering doses of green porphyrin in the absence of purposeful irradiation with light |
11/10/1998 | US5834501 Heterocyclic compounds having anti-diabetic activity and their use |
11/10/1998 | US5834500 Administering derivatives of benzyloxy-benzothiazenes to control release of prostaglandins, leukotrienes, histamines, tachykinins, thromboxanes; analgesics, antiasthmatic, antiinflammatory, wound healing and antitumor agentsagents |
11/10/1998 | US5834498 Ocular hypotensive agents |
11/10/1998 | US5834497 Use of felodipine to treat cerebral dysfunction due to solvent exposure |
11/10/1998 | US5834496 Methods for treating hypertension using optically pure S(-) felodipine |
11/10/1998 | US5834495 Crystalline xamoneline tartrate |
11/10/1998 | US5834494 Pyridylcarbamoyl Indolines |
11/10/1998 | US5834493 Treatment of nervous system disorders |
11/10/1998 | US5834491 Bis(2-aminopyridine)s, preparation method therefor and use thereof for controlling parasitic infections |
11/10/1998 | US5834489 Continuous epidural infusion, minimal motor blockade, anesthetics |
11/10/1998 | US5834487 Inhibition of 26S and 20S proteasome by indanones |
11/10/1998 | US5834486 Antiproliferative, antiprotozoa agents |
11/10/1998 | US5834485 Quinoline sulfonamides and their therapeutic use |
11/10/1998 | US5834483 Method of treating heart failure with endothelin antagonists |
11/10/1998 | US5834482 Heterocyclic chemistry |
11/10/1998 | US5834481 Hypotensive agents |
11/10/1998 | US5834480 Topical application of opioids for treatment of acne and sebaceous gland disorders |
11/10/1998 | US5834479 Method and composition for alleviating pain |
11/10/1998 | US5834478 Morphinan hydroxamic acid compounds |
11/10/1998 | US5834477 Opiate analgesic formulation with improved safety |
11/10/1998 | US5834474 Enantiomerically pure B--D--dioxolane nucleosides with selective anti-hepatitus B virus activity |
11/10/1998 | US5834473 Administering betaine as osmoprotectant with a coccidiostat, for domestic food animals, poultry |
11/10/1998 | US5834472 Low water solubility |
11/10/1998 | US5834471 Amide derivatives as 5HT1D receptor antagonists |
11/10/1998 | US5834470 Decongestants; bronchodilator and antisecretory and -tussive agents; side effect reduction |
11/10/1998 | US5834469 Endothelin receptor antagonists |
11/10/1998 | US5834468 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
11/10/1998 | US5834467 HIV protease inhibitors |
11/10/1998 | US5834466 Administering aldose reductase inhibitor, nicotinic acid or methylene blue |
11/10/1998 | US5834465 Treatment with combined NMDA and non-NMDA antagonists to reduce excitotoxic CNS damage |
11/10/1998 | US5834463 Condensed heterocyclic compounds, their production and use |
11/10/1998 | US5834457 Administering a copper chelating agent to inhibit free radical production of mutant superoxidase dismutase; familial amyotrophic lateral sclerosis |
11/10/1998 | US5834455 Photosensitizers for sensitizing cells |
11/10/1998 | US5834451 Remedy for myotonic dystrophy |
11/10/1998 | US5834450 Doxycycline analogs, effective against organisms resistant to tetracyclines |
11/10/1998 | US5834449 Inhibiting the formation and progression of abnormal vascular dilation and/or aneurysms |
11/10/1998 | US5834448 Dosage form of hydroxocobalamin and its use in cyanide poisoning |
11/10/1998 | US5834447 Thiophene derivatives |
11/10/1998 | US5834446 Nerve process growth modulators |
11/10/1998 | US5834445 Providing a suitable pastel cosmetic color by combining an aqueous solution of a cyclodextrin, a topical carrier,an antioxidant and an organic solution of b-carotene; skin creams |
11/10/1998 | US5834444 Hyaluronic acid and salts thereof inhibit arterial restenosis |
11/10/1998 | US5834443 Composition and method for treating herpes simplex |
11/10/1998 | US5834442 Treatment of prostate cancer |
11/10/1998 | US5834441 Introducing a genetic sequence into a host cell |
11/10/1998 | US5834440 Administering to human muscle cell an effective amount of dna to favor transcription of the dna to produce ribozyme |
11/10/1998 | US5834438 Enhancement of gastric motility, prokinetic agents |